Christopher Garabedian
2012
In 2012, Christopher Garabedian earned a total compensation of $2.6M as Former President and Chief Executive Officer at Sarepta Therapeutics, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $318,500 |
|---|---|
| Option Awards | $1,741,757 |
| Salary | $490,000 |
| Stock Awards | $73,500 |
| Other | $16,754 |
| Total | $2,640,511 |
Garabedian received $1.7M in option awards, accounting for 66% of the total pay in 2012.
Garabedian also received $318.5K in non-equity incentive plan, $490K in salary, $73.5K in stock awards and $16.8K in other compensation.
Rankings
In 2012, Christopher Garabedian's compensation ranked 2,674th out of 11,487 executives tracked by ExecPay. In other words, Garabedian earned more than 76.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,674 out of 11,487 | 77th |
Division Manufacturing | 941 out of 4,253 | 78th |
Major group Chemicals And Allied Products | 212 out of 1,203 | 82nd |
Industry group Drugs | 125 out of 925 | 87th |
Industry Pharmaceutical Preparations | 102 out of 700 | 85th |
Source: SEC filing on April 30, 2015.
Garabedian's colleagues
We found seven more compensation records of executives who worked with Christopher Garabedian at Sarepta Therapeutics in 2012.
2012
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2012
Michael Jacobsen
Sarepta Therapeutics
Vice President, Finance
2012
Jayant Aphale
Sarepta Therapeutics
Senior Vice President, Technical Operations
2012
Effie Toshav
Sarepta Therapeutics